Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hodgkin Disease | 14 | 2022 | 1384 | 1.100 |
Why?
|
Lymphoma, Non-Hodgkin | 9 | 2019 | 1374 | 0.850 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 10 | 2024 | 1433 | 0.790 |
Why?
|
Vincristine | 8 | 2024 | 1040 | 0.760 |
Why?
|
Central Nervous System Neoplasms | 7 | 2023 | 926 | 0.700 |
Why?
|
Lymphoma, Follicular | 5 | 2017 | 460 | 0.650 |
Why?
|
Electronic Mail | 1 | 2020 | 215 | 0.630 |
Why?
|
Vidarabine | 5 | 2024 | 342 | 0.620 |
Why?
|
Lymphoma | 7 | 2023 | 1899 | 0.600 |
Why?
|
Cyclophosphamide | 13 | 2024 | 2234 | 0.600 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 8 | 2024 | 1642 | 0.590 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 23 | 2024 | 11876 | 0.580 |
Why?
|
Retroperitoneal Neoplasms | 2 | 2020 | 335 | 0.580 |
Why?
|
Lymphoma, B-Cell | 5 | 2017 | 945 | 0.450 |
Why?
|
Documentation | 1 | 2020 | 914 | 0.450 |
Why?
|
Neoplasm Staging | 14 | 2020 | 11218 | 0.440 |
Why?
|
Doxorubicin | 8 | 2024 | 2229 | 0.420 |
Why?
|
Arabinonucleosides | 1 | 2013 | 35 | 0.420 |
Why?
|
Neurotoxicity Syndromes | 3 | 2023 | 302 | 0.420 |
Why?
|
Adenine Nucleotides | 1 | 2013 | 111 | 0.420 |
Why?
|
Machado-Joseph Disease | 1 | 2012 | 26 | 0.400 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2023 | 678 | 0.380 |
Why?
|
Prednisone | 7 | 2024 | 1566 | 0.370 |
Why?
|
Electronic Health Records | 3 | 2020 | 4880 | 0.360 |
Why?
|
Medical Oncology | 6 | 2022 | 2340 | 0.350 |
Why?
|
Hematopoietic Stem Cell Transplantation | 12 | 2023 | 5753 | 0.350 |
Why?
|
Methotrexate | 6 | 2015 | 1719 | 0.350 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2011 | 168 | 0.330 |
Why?
|
Anthracyclines | 3 | 2023 | 286 | 0.330 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2013 | 646 | 0.320 |
Why?
|
Immunotherapy, Adoptive | 4 | 2024 | 1503 | 0.310 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 7 | 2014 | 696 | 0.300 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 617 | 0.300 |
Why?
|
Breast Implants | 1 | 2011 | 414 | 0.290 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2011 | 594 | 0.280 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 2006 | 16 | 0.270 |
Why?
|
Patient Care | 1 | 2012 | 629 | 0.260 |
Why?
|
Transplantation Conditioning | 6 | 2014 | 1635 | 0.260 |
Why?
|
Bleomycin | 1 | 2007 | 492 | 0.260 |
Why?
|
Neoplasms | 12 | 2022 | 22350 | 0.260 |
Why?
|
Erythema | 1 | 2007 | 261 | 0.250 |
Why?
|
Neutropenia | 4 | 2019 | 895 | 0.250 |
Why?
|
Transplantation Chimera | 5 | 2004 | 609 | 0.240 |
Why?
|
Remission Induction | 8 | 2019 | 2413 | 0.240 |
Why?
|
Middle Aged | 68 | 2024 | 223267 | 0.240 |
Why?
|
Waldenstrom Macroglobulinemia | 5 | 2014 | 1076 | 0.230 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2006 | 180 | 0.230 |
Why?
|
Stem Cell Transplantation | 5 | 2018 | 1600 | 0.220 |
Why?
|
Hospitalization | 8 | 2020 | 10816 | 0.210 |
Why?
|
Disease-Free Survival | 13 | 2018 | 6853 | 0.210 |
Why?
|
Lymphoma, Mantle-Cell | 2 | 2023 | 238 | 0.210 |
Why?
|
Adenine | 3 | 2024 | 993 | 0.210 |
Why?
|
Positron-Emission Tomography | 6 | 2016 | 6548 | 0.200 |
Why?
|
Recurrence | 11 | 2018 | 8507 | 0.200 |
Why?
|
Humans | 113 | 2024 | 766812 | 0.200 |
Why?
|
Piperidines | 4 | 2024 | 1663 | 0.200 |
Why?
|
Pyrimidines | 6 | 2021 | 3043 | 0.190 |
Why?
|
Leukopoiesis | 1 | 2001 | 54 | 0.190 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 111 | 0.190 |
Why?
|
Busulfan | 5 | 2017 | 264 | 0.190 |
Why?
|
Antigens, CD19 | 1 | 2024 | 444 | 0.190 |
Why?
|
Fund Raising | 1 | 2021 | 49 | 0.190 |
Why?
|
Male | 75 | 2024 | 364154 | 0.190 |
Why?
|
Gene Rearrangement | 3 | 2017 | 1141 | 0.180 |
Why?
|
Bone Marrow Transplantation | 5 | 2003 | 2730 | 0.180 |
Why?
|
Oncogenes | 2 | 2017 | 1232 | 0.180 |
Why?
|
Aged | 49 | 2024 | 171344 | 0.180 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 3 | 2009 | 266 | 0.180 |
Why?
|
Graft vs Host Disease | 10 | 2018 | 3079 | 0.180 |
Why?
|
Female | 70 | 2024 | 396532 | 0.170 |
Why?
|
Adult | 55 | 2024 | 223305 | 0.170 |
Why?
|
Drug Hypersensitivity | 2 | 2021 | 903 | 0.170 |
Why?
|
Data Mining | 2 | 2015 | 560 | 0.160 |
Why?
|
Symporters | 1 | 2022 | 363 | 0.160 |
Why?
|
Capillaries | 2 | 2019 | 755 | 0.160 |
Why?
|
Lymphocyte Depletion | 5 | 2004 | 606 | 0.160 |
Why?
|
Microscopy, Video | 1 | 2019 | 241 | 0.160 |
Why?
|
Transplantation, Autologous | 7 | 2023 | 2127 | 0.160 |
Why?
|
Burkitt Lymphoma | 2 | 2011 | 338 | 0.150 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 | 2004 | 685 | 0.150 |
Why?
|
Vinblastine | 1 | 2019 | 482 | 0.150 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 258 | 0.140 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 849 | 0.140 |
Why?
|
Treatment Outcome | 24 | 2024 | 65286 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 6 | 2018 | 20710 | 0.130 |
Why?
|
Dacarbazine | 1 | 2019 | 552 | 0.130 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 3230 | 0.130 |
Why?
|
Drug Administration Schedule | 5 | 2019 | 4853 | 0.130 |
Why?
|
Biopsy | 5 | 2017 | 6779 | 0.130 |
Why?
|
Hydronephrosis | 1 | 2017 | 274 | 0.120 |
Why?
|
Massachusetts | 5 | 2020 | 8890 | 0.120 |
Why?
|
Monitoring, Ambulatory | 1 | 2019 | 357 | 0.120 |
Why?
|
Stomach Neoplasms | 1 | 2006 | 1480 | 0.120 |
Why?
|
Transplantation, Homologous | 10 | 2018 | 4860 | 0.120 |
Why?
|
Combined Modality Therapy | 7 | 2017 | 8540 | 0.120 |
Why?
|
Natural Language Processing | 2 | 2015 | 1203 | 0.120 |
Why?
|
Resuscitation Orders | 1 | 2017 | 271 | 0.120 |
Why?
|
Central Nervous System | 2 | 2023 | 1345 | 0.120 |
Why?
|
H-Y Antigen | 2 | 2004 | 42 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2012 | 1405 | 0.120 |
Why?
|
Palliative Care | 3 | 2020 | 3640 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2017 | 8623 | 0.110 |
Why?
|
Prognosis | 14 | 2020 | 29959 | 0.110 |
Why?
|
Lichen Planus, Oral | 1 | 2014 | 56 | 0.110 |
Why?
|
Leukocyte Count | 1 | 2018 | 1606 | 0.110 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2013 | 40 | 0.110 |
Why?
|
Hematopoiesis | 2 | 2002 | 2060 | 0.110 |
Why?
|
Telemedicine | 2 | 2023 | 3111 | 0.110 |
Why?
|
Physicians | 2 | 2022 | 4591 | 0.110 |
Why?
|
Aged, 80 and over | 18 | 2019 | 59548 | 0.110 |
Why?
|
Tacrolimus | 3 | 2015 | 753 | 0.110 |
Why?
|
Back Pain | 1 | 2017 | 547 | 0.110 |
Why?
|
Edema | 1 | 2017 | 764 | 0.100 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2014 | 125 | 0.100 |
Why?
|
Sarcopenia | 1 | 2018 | 378 | 0.100 |
Why?
|
Receptors, Notch | 1 | 2017 | 751 | 0.100 |
Why?
|
Retrospective Studies | 20 | 2024 | 81657 | 0.100 |
Why?
|
Lymphocyte Transfusion | 3 | 2002 | 236 | 0.100 |
Why?
|
Polyneuropathies | 1 | 2014 | 139 | 0.100 |
Why?
|
Jaundice | 1 | 2013 | 95 | 0.100 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 718 | 0.100 |
Why?
|
Paraneoplastic Syndromes | 1 | 2014 | 154 | 0.100 |
Why?
|
Sirolimus | 4 | 2015 | 1540 | 0.100 |
Why?
|
Pyrazoles | 2 | 2021 | 2030 | 0.100 |
Why?
|
Enhancer Elements, Genetic | 2 | 2017 | 1366 | 0.100 |
Why?
|
Cerebrospinal Fluid | 1 | 2015 | 540 | 0.100 |
Why?
|
Leg | 1 | 2017 | 1087 | 0.100 |
Why?
|
Cross Infection | 1 | 2021 | 1427 | 0.100 |
Why?
|
Administration, Oral | 3 | 2019 | 4019 | 0.100 |
Why?
|
Silicone Gels | 1 | 2011 | 39 | 0.100 |
Why?
|
Mouth Mucosa | 1 | 2014 | 434 | 0.100 |
Why?
|
Enteropathy-Associated T-Cell Lymphoma | 1 | 2011 | 13 | 0.090 |
Why?
|
Anti-Asthmatic Agents | 1 | 2016 | 572 | 0.090 |
Why?
|
Lymphoma, T-Cell | 1 | 2013 | 308 | 0.090 |
Why?
|
Diagnosis, Differential | 5 | 2017 | 12985 | 0.090 |
Why?
|
Thiotepa | 3 | 2017 | 66 | 0.090 |
Why?
|
Follow-Up Studies | 10 | 2024 | 39312 | 0.090 |
Why?
|
Pelvic Bones | 1 | 1993 | 274 | 0.090 |
Why?
|
Hospice Care | 1 | 2017 | 678 | 0.090 |
Why?
|
Breast Neoplasms | 2 | 2023 | 21162 | 0.090 |
Why?
|
Mediastinal Neoplasms | 1 | 2013 | 403 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2817 | 0.090 |
Why?
|
Nerve Fibers | 1 | 2014 | 706 | 0.090 |
Why?
|
Ambulatory Care Facilities | 1 | 2016 | 939 | 0.090 |
Why?
|
Pathology, Clinical | 1 | 2014 | 374 | 0.090 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2010 | 58 | 0.090 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2010 | 89 | 0.090 |
Why?
|
Pilot Projects | 2 | 2020 | 8728 | 0.080 |
Why?
|
Microfluidics | 1 | 2015 | 650 | 0.080 |
Why?
|
Length of Stay | 3 | 2018 | 6491 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2011 | 15831 | 0.080 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10263 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2017 | 996 | 0.080 |
Why?
|
Injections, Intravenous | 2 | 2010 | 1377 | 0.080 |
Why?
|
Anaphylaxis | 1 | 2016 | 738 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1492 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13489 | 0.080 |
Why?
|
Fatal Outcome | 2 | 2020 | 1838 | 0.080 |
Why?
|
Immunosuppressive Agents | 3 | 2009 | 4215 | 0.080 |
Why?
|
Myeloablative Agonists | 1 | 2009 | 215 | 0.080 |
Why?
|
Immunoconjugates | 1 | 2016 | 976 | 0.080 |
Why?
|
Body Composition | 1 | 2018 | 2441 | 0.080 |
Why?
|
Interleukin-2 | 3 | 2004 | 1895 | 0.080 |
Why?
|
Ki-67 Antigen | 2 | 2012 | 630 | 0.080 |
Why?
|
Patient Readmission | 2 | 2020 | 3283 | 0.080 |
Why?
|
Hematologic Diseases | 2 | 2019 | 502 | 0.070 |
Why?
|
Retinal Diseases | 1 | 2014 | 709 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2006 | 16044 | 0.070 |
Why?
|
Lung | 1 | 2006 | 10068 | 0.070 |
Why?
|
Ventricular Function, Left | 2 | 2023 | 3934 | 0.070 |
Why?
|
Lymph Nodes | 3 | 2017 | 3468 | 0.070 |
Why?
|
B-Lymphocytes | 2 | 2017 | 4787 | 0.070 |
Why?
|
Urinary Bladder | 1 | 1993 | 1155 | 0.070 |
Why?
|
Ascitic Fluid | 1 | 2007 | 189 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1902 | 0.070 |
Why?
|
Disease Progression | 5 | 2012 | 13642 | 0.070 |
Why?
|
Optic Nerve Diseases | 1 | 2010 | 342 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2586 | 0.070 |
Why?
|
Wounds, Nonpenetrating | 1 | 1993 | 807 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 3 | 2004 | 3738 | 0.070 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13644 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2016 | 2028 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2903 | 0.070 |
Why?
|
Immunophenotyping | 4 | 2016 | 1867 | 0.060 |
Why?
|
Prosthesis Failure | 1 | 2011 | 1208 | 0.060 |
Why?
|
Exotoxins | 2 | 1997 | 123 | 0.060 |
Why?
|
Herpesviridae Infections | 1 | 2007 | 268 | 0.060 |
Why?
|
Cause of Death | 2 | 2017 | 3717 | 0.060 |
Why?
|
Herpesvirus 8, Human | 1 | 2007 | 254 | 0.060 |
Why?
|
Pericardial Effusion | 1 | 2007 | 246 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2004 | 4652 | 0.060 |
Why?
|
Central Nervous System Diseases | 1 | 2009 | 518 | 0.060 |
Why?
|
Patient Discharge | 1 | 2017 | 3466 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2012 | 9407 | 0.060 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2004 | 429 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 2 | 2019 | 5690 | 0.060 |
Why?
|
Pleural Effusion | 1 | 2007 | 344 | 0.060 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 663 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2012 | 10451 | 0.050 |
Why?
|
Thiazoles | 1 | 2011 | 1529 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2017 | 5344 | 0.050 |
Why?
|
Diphtheria Toxin | 1 | 2004 | 253 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15652 | 0.050 |
Why?
|
Retina | 1 | 2014 | 2660 | 0.050 |
Why?
|
Celiac Disease | 1 | 2011 | 821 | 0.050 |
Why?
|
Isoantibodies | 2 | 2004 | 681 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15912 | 0.050 |
Why?
|
Risk | 2 | 2016 | 9602 | 0.050 |
Why?
|
Mastectomy | 1 | 2011 | 1861 | 0.050 |
Why?
|
Piperazines | 2 | 2004 | 2547 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2015 | 3831 | 0.050 |
Why?
|
Mutation | 3 | 2019 | 30214 | 0.050 |
Why?
|
Breast | 1 | 2011 | 1972 | 0.050 |
Why?
|
Neoplasms, Second Primary | 1 | 2010 | 1062 | 0.050 |
Why?
|
Echocardiography | 1 | 2015 | 5038 | 0.050 |
Why?
|
Young Adult | 11 | 2020 | 59939 | 0.050 |
Why?
|
Methods | 1 | 2002 | 1065 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2014 | 5330 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2014 | 2510 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5389 | 0.050 |
Why?
|
Gene Frequency | 2 | 2013 | 3624 | 0.050 |
Why?
|
Perceptual Masking | 1 | 1982 | 90 | 0.050 |
Why?
|
Heart Failure | 2 | 2023 | 11879 | 0.050 |
Why?
|
Fractures, Bone | 1 | 1993 | 2043 | 0.050 |
Why?
|
Reoperation | 1 | 2011 | 4325 | 0.050 |
Why?
|
Gastrectomy | 1 | 2006 | 693 | 0.050 |
Why?
|
Liver Transplantation | 1 | 2013 | 2416 | 0.050 |
Why?
|
Cytarabine | 2 | 2014 | 696 | 0.040 |
Why?
|
Adolescent | 10 | 2020 | 88902 | 0.040 |
Why?
|
Surge Capacity | 1 | 2020 | 48 | 0.040 |
Why?
|
Skin | 1 | 2014 | 4499 | 0.040 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2018 | 4628 | 0.040 |
Why?
|
Censuses | 1 | 2021 | 198 | 0.040 |
Why?
|
Radiography | 2 | 2006 | 6968 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2011 | 15425 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2019 | 14653 | 0.040 |
Why?
|
Fatigue | 2 | 2020 | 1555 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2024 | 12430 | 0.040 |
Why?
|
Survival Analysis | 4 | 2019 | 10101 | 0.040 |
Why?
|
Inpatients | 2 | 2021 | 2566 | 0.040 |
Why?
|
Rheumatic Diseases | 1 | 2006 | 657 | 0.040 |
Why?
|
Cohort Studies | 7 | 2019 | 41706 | 0.040 |
Why?
|
Depression | 1 | 2018 | 8225 | 0.040 |
Why?
|
Psychometrics | 2 | 2019 | 3060 | 0.040 |
Why?
|
Dyspnea | 1 | 2006 | 1352 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12246 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6514 | 0.040 |
Why?
|
Salvage Therapy | 3 | 2011 | 1274 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2008 | 1659 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3796 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 859 | 0.040 |
Why?
|
Anti-Retroviral Agents | 1 | 2007 | 1787 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 6266 | 0.040 |
Why?
|
Self Report | 2 | 2019 | 3771 | 0.040 |
Why?
|
Sodium | 1 | 2022 | 1594 | 0.030 |
Why?
|
Home Infusion Therapy | 1 | 2016 | 18 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9244 | 0.030 |
Why?
|
Cell Lineage | 2 | 2003 | 2573 | 0.030 |
Why?
|
Survival Rate | 4 | 2015 | 12826 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2002 | 962 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2021 | 1012 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2019 | 647 | 0.030 |
Why?
|
Prospective Studies | 5 | 2022 | 54872 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10619 | 0.030 |
Why?
|
Incidence | 4 | 2018 | 21527 | 0.030 |
Why?
|
Psychological Tests | 1 | 2018 | 642 | 0.030 |
Why?
|
Receptors, Interleukin-2 | 1 | 1997 | 565 | 0.030 |
Why?
|
Stroke Volume | 2 | 2023 | 5618 | 0.030 |
Why?
|
Desensitization, Immunologic | 1 | 2021 | 546 | 0.030 |
Why?
|
Treatment Failure | 2 | 2013 | 2659 | 0.030 |
Why?
|
Hydroxamic Acids | 1 | 2018 | 483 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2002 | 4410 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2002 | 1802 | 0.030 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2016 | 347 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5367 | 0.030 |
Why?
|
United States | 4 | 2021 | 72945 | 0.030 |
Why?
|
Cell Shape | 1 | 2016 | 372 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2015 | 190 | 0.030 |
Why?
|
ADP Ribose Transferases | 1 | 1995 | 90 | 0.030 |
Why?
|
p300-CBP Transcription Factors | 1 | 2015 | 147 | 0.030 |
Why?
|
Hospices | 1 | 2017 | 245 | 0.030 |
Why?
|
Immunotoxins | 1 | 1995 | 175 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3610 | 0.030 |
Why?
|
World Health Organization | 2 | 2011 | 1327 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2015 | 322 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23618 | 0.030 |
Why?
|
Gene Duplication | 1 | 2015 | 315 | 0.030 |
Why?
|
Genes, myc | 1 | 2015 | 391 | 0.030 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 1 | 2014 | 102 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2002 | 22248 | 0.030 |
Why?
|
Unified Medical Language System | 1 | 2014 | 88 | 0.030 |
Why?
|
Physician's Role | 1 | 2020 | 925 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2015 | 451 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2017 | 11657 | 0.030 |
Why?
|
Visual Perception | 1 | 1982 | 1392 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2021 | 1226 | 0.030 |
Why?
|
Microcirculation | 1 | 2018 | 1282 | 0.030 |
Why?
|
Endocytosis | 1 | 1997 | 951 | 0.030 |
Why?
|
Narration | 1 | 2015 | 223 | 0.030 |
Why?
|
Periodicity | 1 | 2014 | 347 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 857 | 0.030 |
Why?
|
Acetylation | 1 | 2015 | 1055 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 367 | 0.030 |
Why?
|
Fundus Oculi | 1 | 2014 | 560 | 0.020 |
Why?
|
Hepatorenal Syndrome | 1 | 2013 | 76 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 2011 | 0.020 |
Why?
|
Electroretinography | 1 | 2014 | 524 | 0.020 |
Why?
|
Sulfonamides | 1 | 2021 | 1982 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3853 | 0.020 |
Why?
|
Exanthema | 1 | 2016 | 502 | 0.020 |
Why?
|
Rupture | 1 | 1993 | 444 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1140 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8734 | 0.020 |
Why?
|
Virulence Factors | 1 | 1995 | 498 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 4780 | 0.020 |
Why?
|
Oligopeptides | 1 | 2016 | 1195 | 0.020 |
Why?
|
Eye | 1 | 1995 | 711 | 0.020 |
Why?
|
Aspergillus fumigatus | 1 | 1992 | 158 | 0.020 |
Why?
|
Secondary Prevention | 2 | 2011 | 1469 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2015 | 1524 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2023 | 3618 | 0.020 |
Why?
|
Ifosfamide | 1 | 2011 | 233 | 0.020 |
Why?
|
Cauda Equina | 1 | 2010 | 45 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4340 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18397 | 0.020 |
Why?
|
Aspergillosis | 1 | 1992 | 242 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10745 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1495 | 0.020 |
Why?
|
Indoles | 1 | 2018 | 1834 | 0.020 |
Why?
|
Leukocytes | 1 | 2018 | 2034 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 17089 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1561 | 0.020 |
Why?
|
Time Factors | 4 | 2010 | 40149 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2014 | 2228 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2015 | 1392 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2017 | 996 | 0.020 |
Why?
|
Etoposide | 1 | 2011 | 638 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2519 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3605 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 416 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 1991 | 453 | 0.020 |
Why?
|
Proteins | 1 | 2003 | 6002 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2952 | 0.020 |
Why?
|
Cost of Illness | 1 | 2018 | 1949 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2014 | 1086 | 0.020 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 1968 | 152 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2533 | 0.020 |
Why?
|
Behavior | 1 | 1991 | 538 | 0.020 |
Why?
|
Karyotyping | 1 | 2010 | 1176 | 0.020 |
Why?
|
Genotype | 1 | 2002 | 13036 | 0.020 |
Why?
|
Benzamides | 2 | 2004 | 1375 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2010 | 608 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2011 | 543 | 0.020 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2009 | 221 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2045 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2011 | 492 | 0.020 |
Why?
|
Hematologic Neoplasms | 3 | 2004 | 1925 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 42577 | 0.020 |
Why?
|
Dexamethasone | 1 | 2014 | 1962 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5306 | 0.020 |
Why?
|
Immune System | 2 | 2002 | 800 | 0.020 |
Why?
|
Quality of Life | 2 | 2019 | 13476 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2011 | 36570 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2703 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 4570 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2329 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2014 | 1608 | 0.020 |
Why?
|
Optic Disk | 1 | 2010 | 421 | 0.020 |
Why?
|
Cocaine | 1 | 1991 | 944 | 0.020 |
Why?
|
Fibrosis | 1 | 2013 | 2078 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6066 | 0.020 |
Why?
|
Internationality | 1 | 2011 | 1006 | 0.020 |
Why?
|
Terminal Care | 1 | 2017 | 1769 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4114 | 0.020 |
Why?
|
Neutrophils | 1 | 2018 | 3782 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7841 | 0.020 |
Why?
|
Chromosomes, Human, Y | 1 | 2006 | 163 | 0.020 |
Why?
|
Anxiety | 1 | 2020 | 4668 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2015 | 4249 | 0.010 |
Why?
|
Histones | 1 | 2015 | 2595 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1805 | 0.010 |
Why?
|
Child | 4 | 2016 | 80670 | 0.010 |
Why?
|
Radiotherapy | 1 | 2011 | 1497 | 0.010 |
Why?
|
HIV Infections | 2 | 2011 | 17532 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2809 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3942 | 0.010 |
Why?
|
Simplexvirus | 1 | 1968 | 805 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2002 | 5193 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2002 | 20146 | 0.010 |
Why?
|
Cytogenetics | 1 | 2004 | 198 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 2004 | 438 | 0.010 |
Why?
|
Infant | 3 | 2016 | 36459 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 2004 | 6306 | 0.010 |
Why?
|
Tissue Donors | 2 | 2003 | 2392 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3360 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2006 | 11094 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1992 | 2204 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9326 | 0.010 |
Why?
|
Anemia | 1 | 2012 | 1514 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4356 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3667 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3828 | 0.010 |
Why?
|
Globins | 1 | 2003 | 405 | 0.010 |
Why?
|
Spinal Cord | 1 | 2011 | 1811 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 24299 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2010 | 1540 | 0.010 |
Why?
|
Bone Marrow Examination | 1 | 2002 | 155 | 0.010 |
Why?
|
Syndrome | 1 | 2009 | 3271 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2010 | 1172 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8928 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2004 | 726 | 0.010 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2003 | 303 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2003 | 12795 | 0.010 |
Why?
|
Graft Survival | 2 | 2004 | 3904 | 0.010 |
Why?
|
Cytogenetic Analysis | 1 | 2002 | 270 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2011 | 2209 | 0.010 |
Why?
|
Gene Dosage | 1 | 2006 | 1211 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2003 | 1062 | 0.010 |
Why?
|
Consensus | 1 | 2011 | 3208 | 0.010 |
Why?
|
Kidney Diseases | 1 | 1992 | 2101 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11062 | 0.010 |
Why?
|
Probability | 1 | 2006 | 2476 | 0.010 |
Why?
|
DEAD-box RNA Helicases | 1 | 2003 | 385 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 1989 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 13050 | 0.010 |
Why?
|
Haplotypes | 1 | 2006 | 2726 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5990 | 0.010 |
Why?
|
Erythropoiesis | 1 | 2003 | 692 | 0.010 |
Why?
|
Steroids | 1 | 2004 | 936 | 0.010 |
Why?
|
Clone Cells | 1 | 2002 | 1670 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2002 | 1352 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2002 | 812 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8065 | 0.010 |
Why?
|
Drug Resistance | 1 | 2004 | 1592 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9613 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4278 | 0.010 |
Why?
|
Registries | 1 | 2014 | 8352 | 0.010 |
Why?
|
Liver | 1 | 2013 | 7571 | 0.010 |
Why?
|
Epitopes | 1 | 2003 | 2526 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 74889 | 0.010 |
Why?
|
Models, Genetic | 1 | 2006 | 3446 | 0.010 |
Why?
|
Pattern Recognition, Visual | 1 | 1982 | 820 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12808 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2002 | 1852 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12536 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2012 | 26387 | 0.010 |
Why?
|
Alleles | 1 | 2006 | 6896 | 0.010 |
Why?
|
Drug Administration Routes | 1 | 1995 | 152 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2002 | 2413 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1995 | 411 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2003 | 2429 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2002 | 3157 | 0.010 |
Why?
|
Ophthalmic Solutions | 1 | 1995 | 312 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 18076 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7240 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2004 | 5502 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2002 | 2571 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2003 | 2645 | 0.010 |
Why?
|
DNA Primers | 1 | 1997 | 2826 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2004 | 4559 | 0.010 |
Why?
|
Base Sequence | 1 | 2003 | 12415 | 0.010 |
Why?
|
Orbit | 1 | 1995 | 459 | 0.010 |
Why?
|
Adsorption | 2 | 1969 | 198 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1995 | 2275 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2009 | 5182 | 0.010 |
Why?
|
Carbon Isotopes | 2 | 1969 | 453 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81898 | 0.010 |
Why?
|
Ligands | 1 | 1997 | 3274 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9358 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 1995 | 922 | 0.010 |
Why?
|
Chlamydia | 1 | 1969 | 33 | 0.000 |
Why?
|
Maternal Behavior | 1 | 1991 | 307 | 0.000 |
Why?
|
Animals | 3 | 2017 | 168939 | 0.000 |
Why?
|
Centrifugation, Density Gradient | 1 | 1968 | 297 | 0.000 |
Why?
|
Thymidine | 1 | 1968 | 297 | 0.000 |
Why?
|
Motor Skills | 1 | 1991 | 519 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1997 | 6507 | 0.000 |
Why?
|
Tritium | 1 | 1968 | 707 | 0.000 |
Why?
|
Culture Techniques | 1 | 1968 | 529 | 0.000 |
Why?
|
Pseudomonas aeruginosa | 1 | 1995 | 1276 | 0.000 |
Why?
|
Deoxyribonucleases | 1 | 1968 | 209 | 0.000 |
Why?
|
Leucine | 1 | 1968 | 547 | 0.000 |
Why?
|
Bile Acids and Salts | 1 | 1968 | 398 | 0.000 |
Why?
|
Cell Line | 2 | 1997 | 15564 | 0.000 |
Why?
|
Heparin | 2 | 1969 | 1636 | 0.000 |
Why?
|
Brain | 1 | 2011 | 27158 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1997 | 18986 | 0.000 |
Why?
|
Rats | 1 | 1995 | 23717 | 0.000 |
Why?
|
Pregnancy | 1 | 1991 | 30236 | 0.000 |
Why?
|
Haplorhini | 1 | 1969 | 520 | 0.000 |
Why?
|
Amnion | 1 | 1969 | 204 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1969 | 2551 | 0.000 |
Why?
|
Amino Acids | 1 | 1969 | 1711 | 0.000 |
Why?
|
Bacterial Proteins | 1 | 1969 | 3833 | 0.000 |
Why?
|
Kidney | 1 | 1969 | 7073 | 0.000 |
Why?
|